Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07534020 · ClinicalTrials.gov registry record · NA
Acute Amino Acid Response of Proprietary Beverages
A NA study, sponsored by Shaklee Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT07534020: Recruiting NA study, sponsored by Shaklee Corporation.
NCT07534020 is a NA study that is actively recruiting participants, run by Shaklee Corporation. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07534020, a NA study, is actively recruiting participants, sponsored by Shaklee Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate post-meal amino acid in response to a proprietary beverages in generally healthy adults.
Interventions
- OTHER Test carbonated protein beverage
- OTHER Test protein beverage
- OTHER Control protein beverage.
- OTHER Control non-carbonated beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2026-04-03 |
| Est. Completion | 2026-05 |
| Phase | NA |
What NCT07534020 shows while recruiting
NCT07534020 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Test carbonated protein beverage is the first listed.
NCT07534020 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07534020 about?
NCT07534020 is a clinical study titled "Acute Amino Acid Response of Proprietary Beverages". The primary objective of this study is to evaluate post-meal amino acid in response to a proprietary beverages in generally healthy adults.
What is the current status of trial NCT07534020?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-04-03. Estimated completion is 2026-05.
What interventions are being tested in trial NCT07534020?
The interventions under investigation include: Test carbonated protein beverage (OTHER), Test protein beverage (OTHER), Control protein beverage. (OTHER), Control non-carbonated beverage (OTHER).
Who is sponsoring clinical trial NCT07534020?
This trial is sponsored by Shaklee Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07534020's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI